Page last updated: 2024-08-21

nandrolone and Prostatic Neoplasms

nandrolone has been researched along with Prostatic Neoplasms in 45 studies

*Prostatic Neoplasms: Tumors or cancer of the PROSTATE. [MeSH]

Research

Studies (45)

Timeframe	Studies, this research(%)	All Research%
pre-1990	7 (15.56)	18.7374
1990's	17 (37.78)	18.2507
2000's	15 (33.33)	29.6817
2010's	4 (8.89)	24.3611
2020's	2 (4.44)	2.80

Authors

Authors	Studies
Carlson, KE; Katzenellenbogen, JA; Liu, A	1
Bonasera, TA; Chi, DY; Choe, YS; Katzenellenbogen, JA; Lidström, PJ; Welch, MJ	1
Goyal, S; Kumar, N; Kumar, R; Madan, R	1
Gang, X; Huang, H; Wang, G	1
Gooderham, NJ; Koufaris, C; Powell, C; Segal, CV	1
Acevedo, C; Cabezas, J; Castellón, EA; Contreras, HR; Huidobro, C; Mendoza, P; Noé, G; Sánchez, C; Vergara, J	1
Anchoori, RK; Bakare, O; Hallur, G; Isaacs, JT; Kageyama, Y; Khan, SR; Singh, P	1
Barkey, RJ; Bidosee, M; Karry, R; Weiss-Messer, E	2
Bevan, CL; Brooke, GN; Culley, RL; Dart, DA; Gamble, SC; Gaughan, L; Mann, DJ; McCracken, SR; Powell, SM; Robson, CN; Spencer-Dene, B; Wait, R; Walker, MM; Waxman, J	1
Lu, L; Schulz, H; Wolf, DA	1
Jiang, F; Kozlowski, JM; Pins, M; Wang, Z; Xiao, W; Zhang, Q	1
MacBride, MM; Muddana, SS; Peterson, BR; Price, AM	1
Didier, A; Hartel, A; Meyer, HH; Ulbrich, SE; Wierer, M	1
Chung, BH; Lee, HY; Lee, JS; Young, CY	1
Ancrile, BB; Cunha, GR; Tokar, EJ; Webber, MM	1
Guo, YL; Lai, YQ; Mao, ZB; Na, YQ; Xin, DQ; You, R; Zhu, XH	1
Kirdani, RY; Müntzing, J; Murphy, GP; Williams, PD	1
Esquenet, M; Heyns, W; Rombauts, W; Swinnen, JV; Verhoeven, G	1
Murtha, P; Tindall, DJ; Young, CY	1
Blaschke, D; Hermeking, H; Herzinger, T; Hörz, W; Wolf, DA	1
Bonasera, TA; Choe, YS; Cutler, PD; Dobkin, JA; Katzenellenbogen, JA; Lich, LL; O'Neil, JP; Welch, MJ; Xu, M	1
Esquenet, M; Goossens, K; Heyns, W; Swinnen, JV; Verhoeven, G	1
Prescott, JL; Tindall, DJ	1
Eisenbrand, G; Schneider, MR; Tang, W	1
Bergert, ER; Castro, MR; Heufelder, AE; McIver, B; Morris, JC; Spitzweg, C; Tindall, DJ; Young, CY; Zhang, S	1
Hill, TM; Kumar, A; Mikolajczyk, SD; Millar, LS; Saedi, MS	1
Betts, AM; Collett, GP; Cook, S; Johnson, MI; Neal, DE; Pulimood, AB; Robson, CN	1
Bello-DeOcampo, D; Bice, G; DeMendonca-Calaca, W; Kleinman, HK; Quader, ST; Storto, PD; Webber, MM; Williams, DE	1
Young, CY; Zhang, JS; Zhu, W	1
Bartsch, G; Culig, Z; Klocker, H; Levy-Rimler, G; Lupowitz, Z; Matzkin, H; Rimler, A; Zisapel, N	1
Holtzhausen, GH	1
Andrews, PE; Montgomery, BT; Tindall, DJ; Young, CY	1
Carruba, G; Castagnetta, L; Cusimano, R; Fecarotta, E; Lo Casto, M; Pavone-Macaluso, M	1
Habib, FK; MacDonald, A	1
Allman, DR; Krongrad, A; McPhaul, MJ; Wilson, CM; Wilson, JD	1
Reinach, P; Socci, R; Steinsapir, J	1
Arbusow, V; Bojar, H; Fittler, F; Klobeck, HG; Schulz, P; Wolf, D	1
Olea, N; Sakabe, K; Sonnenschein, C; Soto, AM	1
Brandes, SJ; Katzenellenbogen, JA	1
Haugen, OA	1
Alcini, E; Alquati, P; Pola, P; Ronzoni, G	1
Dresh, C; Laprevotte, I; Najean, Y	1

Reviews

2 review(s) available for nandrolone and Prostatic Neoplasms

Article	Year
[Clinical aspects of the anti-androgens]. South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde, 1979, Mar-24, Volume: 55, Issue:13 Topics: 17-Ketosteroids; Acne Vulgaris; Adrenal Hyperplasia, Congenital; Androgen Antagonists; Androgens; Androsterone; Contraceptives, Oral, Hormonal; Cyclopentanes; Cyproterone; Dermatitis, Seborrheic; Dihydrotestosterone; Estradiol Congeners; Female; Follicle Stimulating Hormone; Glucocorticoids; Hirsutism; Humans; Hydroxysteroids; Luteinizing Hormone; Male; Medroxyprogesterone; Nandrolone; Prostatic Neoplasms; Receptors, Androgen; Sex Hormone-Binding Globulin; Steroids; Testosterone	1979
Fundamental considerations in the design of fluorine-18 labeled progestins and androgens as imaging agents for receptor-positive tumors of the breast and prostate. International journal of radiation applications and instrumentation. Part B, Nuclear medicine and biology, 1988, Volume: 15, Issue:1 Topics: Androgens; Breast Neoplasms; Female; Fluorine Radioisotopes; Humans; Male; Nandrolone; Neoplasms, Hormone-Dependent; Progesterone; Progesterone Congeners; Prostatic Neoplasms; Protein Binding; Radionuclide Imaging; Receptors, Androgen; Receptors, Estrogen; Sex Hormone-Binding Globulin; Structure-Activity Relationship; Testosterone; Transcortin	1988

Article

Year

[Clinical aspects of the anti-androgens].

South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde, 1979, Mar-24, Volume: 55, Issue:13

Topics: 17-Ketosteroids; Acne Vulgaris; Adrenal Hyperplasia, Congenital; Androgen Antagonists; Androgens; Androsterone; Contraceptives, Oral, Hormonal; Cyclopentanes; Cyproterone; Dermatitis, Seborrheic; Dihydrotestosterone; Estradiol Congeners; Female; Follicle Stimulating Hormone; Glucocorticoids; Hirsutism; Humans; Hydroxysteroids; Luteinizing Hormone; Male; Medroxyprogesterone; Nandrolone; Prostatic Neoplasms; Receptors, Androgen; Sex Hormone-Binding Globulin; Steroids; Testosterone

1979

Fundamental considerations in the design of fluorine-18 labeled progestins and androgens as imaging agents for receptor-positive tumors of the breast and prostate.

International journal of radiation applications and instrumentation. Part B, Nuclear medicine and biology, 1988, Volume: 15, Issue:1

Topics: Androgens; Breast Neoplasms; Female; Fluorine Radioisotopes; Humans; Male; Nandrolone; Neoplasms, Hormone-Dependent; Progesterone; Progesterone Congeners; Prostatic Neoplasms; Protein Binding; Radionuclide Imaging; Receptors, Androgen; Receptors, Estrogen; Sex Hormone-Binding Globulin; Structure-Activity Relationship; Testosterone; Transcortin

1988

Other Studies

43 other study(ies) available for nandrolone and Prostatic Neoplasms

Article	Year
Synthesis of high affinity fluorine-substituted ligands for the androgen receptor. Potential agents for imaging prostatic cancer by positron emission tomography. Journal of medicinal chemistry, 1992, May-29, Volume: 35, Issue:11 Topics: Androgens; Animals; Dihydrotestosterone; Estrenes; Fluorine; Male; Metribolone; Molecular Conformation; Molecular Structure; Nandrolone; Prostate; Prostatic Neoplasms; Rats; Receptors, Androgen; Structure-Activity Relationship; Testosterone; Tomography, Emission-Computed	1992
Synthesis of 11 beta-[18F]fluoro-5 alpha-dihydrotestosterone and 11 beta-[18F]fluoro-19-nor-5 alpha-dihydrotestosterone: preparation via halofluorination-reduction, receptor binding, and tissue distribution. Journal of medicinal chemistry, 1995, Mar-03, Volume: 38, Issue:5 Topics: Animals; Dihydrotestosterone; Fluorine Radioisotopes; Isotope Labeling; Male; Oxidation-Reduction; Prostatic Neoplasms; Radionuclide Imaging; Rats; Rats, Sprague-Dawley; Receptors, Androgen; Solubility; Testosterone Congeners; Tissue Distribution	1995
Nandrolone-Induced Tumor Progression in Hormone-Sensitive Prostate Cancer. Clinical nuclear medicine, 2022, Apr-01, Volume: 47, Issue:4 Topics: Androgen Antagonists; Gonadotropin-Releasing Hormone; Humans; Male; Nandrolone; Oligopeptides; Prostatic Neoplasms	2022
Nandrolone-Induced Tumor Progression in Hormone-Sensitive Prostate Cancer: Erratum. Clinical nuclear medicine, 2022, 05-01, Volume: 47, Issue:5 Topics: Androgen Antagonists; Humans; Male; Nandrolone; Prostatic Neoplasms	2022
Androgens regulate SMAD ubiquitination regulatory factor-1 expression and prostate cancer cell invasion. The Prostate, 2015, Volume: 75, Issue:6 Topics: Cell Line, Tumor; Gene Expression Regulation, Neoplastic; Humans; Male; Nandrolone; Neoplasm Invasiveness; Prostatic Neoplasms; Receptors, Androgen; Transcription, Genetic; Ubiquitin-Protein Ligases	2015
Effects of treatment with androgen receptor ligands on microRNA expression of prostate cancer cells. Toxicology, 2015, Jul-03, Volume: 333 Topics: Androgen Antagonists; Androgens; Anilides; Antineoplastic Agents, Hormonal; Cell Line, Tumor; Cell Proliferation; Dihydrotestosterone; Dose-Response Relationship, Drug; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Humans; Kallikreins; Ligands; Male; MicroRNAs; Nandrolone; Neoplasms, Hormone-Dependent; Nitriles; Oligonucleotide Array Sequence Analysis; Prostate-Specific Antigen; Prostatic Neoplasms; Real-Time Polymerase Chain Reaction; Receptors, Androgen; Time Factors; Tosyl Compounds	2015
Evaluation of MENT on primary cell cultures from benign prostatic hyperplasia and prostate carcinoma. International journal of andrology, 2009, Volume: 32, Issue:6 Topics: Androgens; Dihydrotestosterone; Finasteride; Humans; Male; Nandrolone; Prostate; Prostate-Specific Antigen; Prostatic Hyperplasia; Prostatic Neoplasms; Reverse Transcriptase Polymerase Chain Reaction; Testosterone; Testosterone Congeners	2009
Rational design of novel antiandrogens for neutralizing androgen receptor function in hormone refractory prostate cancer. The Prostate, 2008, Oct-01, Volume: 68, Issue:14 Topics: Androgen Antagonists; Androgen Receptor Antagonists; Cell Growth Processes; Cell Line, Tumor; Drug Design; Fluorescence Polarization; Formazans; Humans; Male; Nandrolone; Neoplasms, Hormone-Dependent; Prostate-Specific Antigen; Prostatic Neoplasms; Receptors, Androgen; Tetrazolium Salts; Transcription, Genetic	2008
Regulation of growth hormone receptors in human prostate cancer cell lines. Molecular and cellular endocrinology, 2009, Oct-15, Volume: 309, Issue:1-2 Topics: Androgen Antagonists; Androgens; Cell Line, Tumor; Culture Media; Culture Media, Serum-Free; Estradiol; Gene Expression Regulation, Neoplastic; Human Growth Hormone; Humans; Hydrocortisone; Insulin-Like Growth Factor I; Insulin-Like Growth Factor II; Iodine Radioisotopes; Male; Mutant Proteins; Nandrolone; Prostatic Neoplasms; Protein Isoforms; Receptors, Somatotropin; RNA, Messenger; Triiodothyronine	2009
Growth hormone affects gene expression and proliferation in human prostate cancer cells. International journal of andrology, 2011, Volume: 34, Issue:2 Topics: Cell Line, Tumor; Estradiol; Gene Expression Regulation; Human Growth Hormone; Humans; Insulin-Like Growth Factor I; Insulin-Like Growth Factor II; Male; Nandrolone; Prostatic Neoplasms; Receptor, IGF Type 1; Receptor, IGF Type 2; Receptors, Estradiol; Triiodothyronine	2011
FUS/TLS is a novel mediator of androgen-dependent cell-cycle progression and prostate cancer growth. Cancer research, 2011, Feb-01, Volume: 71, Issue:3 Topics: Bone Neoplasms; Cell Cycle; Cell Growth Processes; Cell Line, Tumor; Down-Regulation; Humans; Immunohistochemistry; Male; Nandrolone; Neoplasms, Hormone-Dependent; Prostatic Neoplasms; Receptors, Androgen; RNA-Binding Protein FUS	2011
The F-box protein SKP2 mediates androgen control of p27 stability in LNCaP human prostate cancer cells. BMC cell biology, 2002, Aug-20, Volume: 3 Topics: Androgens; Cell Cycle; Cell Cycle Proteins; Cyclin-Dependent Kinase Inhibitor p27; Cyclin-Dependent Kinases; Down-Regulation; G1 Phase; Genes, Tumor Suppressor; Humans; Ligases; Male; Nandrolone; Prostatic Neoplasms; S-Phase Kinase-Associated Proteins; Testosterone Congeners; Tumor Cells, Cultured; Tumor Suppressor Proteins; Ubiquitin; Ubiquitin-Protein Ligases; Up-Regulation	2002
Suppression of prostate tumor growth by U19, a novel testosterone-regulated apoptosis inducer. Cancer research, 2003, Aug-01, Volume: 63, Issue:15 Topics: Amino Acid Sequence; Animals; Apoptosis; DNA Methylation; Down-Regulation; Gene Expression Regulation, Neoplastic; Humans; Loss of Heterozygosity; Male; Mice; Mice, Nude; Molecular Sequence Data; Nandrolone; Neoplasm Transplantation; Promoter Regions, Genetic; Prostatic Neoplasms; Transcription Factors; Transplantation, Heterologous; Tumor Cells, Cultured; Tumor Suppressor Proteins	2003
11beta-alkyl-Delta9-19-nortestosterone derivatives: high-affinity ligands and potent partial agonists of the androgen receptor. Journal of medicinal chemistry, 2004, Oct-07, Volume: 47, Issue:21 Topics: Androgen Antagonists; Androgen Receptor Antagonists; Androgens; Animals; Antineoplastic Agents; Cell Line, Tumor; CHO Cells; Cricetinae; Cyproterone Acetate; Dimerization; Humans; Ligands; Male; Mifepristone; Nandrolone; Prostatic Neoplasms; Receptors, Androgen; Structure-Activity Relationship	2004
Characterisation of steroid receptor expression in the human prostate carcinoma cell line 22RV1 and quantification of androgen effects on mRNA regulation of prostate-specific genes. The Journal of steroid biochemistry and molecular biology, 2004, Volume: 92, Issue:3 Topics: Androgens; Carcinoma; Estrogen Receptor alpha; Estrogen Receptor beta; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Humans; Male; Nandrolone; Prostate-Specific Antigen; Prostatic Neoplasms; Receptors, Progesterone; Receptors, Steroid; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger	2004
Perillyl alcohol inhibits the expression and function of the androgen receptor in human prostate cancer cells. Cancer letters, 2006, May-18, Volume: 236, Issue:2 Topics: Androgen Receptor Antagonists; Antineoplastic Agents; Cell Line, Tumor; Cell Proliferation; Dose-Response Relationship, Drug; Genes, Reporter; Humans; Luciferases; Male; Monoterpenes; Nandrolone; Promoter Regions, Genetic; Prostate-Specific Antigen; Prostatic Neoplasms; Proto-Oncogene Proteins c-jun; Receptors, Androgen; Tissue Kallikreins; Transcriptional Activation; Transfection	2006
Stem/progenitor and intermediate cell types and the origin of human prostate cancer. Differentiation; research in biological diversity, 2005, Volume: 73, Issue:9-10 Topics: Antigens, Differentiation; Cell Differentiation; Cell Line; Clone Cells; Epithelial Cells; Humans; Male; Nandrolone; Prostate-Specific Antigen; Prostatic Neoplasms; Receptors, Androgen; Stem Cells	2005
[Regulation of expression of pituitary tumor transforming gene 1 (PTTG1) by androgen in prostate cancer]. Beijing da xue xue bao. Yi xue ban = Journal of Peking University. Health sciences, 2005, Dec-18, Volume: 37, Issue:6 Topics: Adenocarcinoma; Animals; Blotting, Northern; Cell Line, Tumor; Gene Expression; Humans; Immunohistochemistry; Male; Nandrolone; Neoplasm Proteins; Orchiectomy; Prostate; Prostatic Neoplasms; Rats; Rats, Sprague-Dawley; RNA, Messenger; Securin; Testosterone Congeners	2005
Effect of LS 1727, a nitrosocarbamate of 19-nortestosterone, on the R-3327 rat prostatic adenocarcinoma. Research communications in chemical pathology and pharmacology, 1981, Volume: 32, Issue:2 Topics: Adenocarcinoma; Animals; Antineoplastic Agents; Dihydrotestosterone; Male; Nandrolone; Neoplasms, Experimental; Prostatic Neoplasms; Rats	1981
Androgen regulation of the messenger RNA encoding diazepam-binding inhibitor/acyl-CoA-binding protein in the human prostatic adenocarcinoma cell line LNCaP. Molecular and cellular endocrinology, 1994, Volume: 104, Issue:2 Topics: Adenocarcinoma; Androgens; Blotting, Northern; Carrier Proteins; Cloning, Molecular; Cycloheximide; Diazepam Binding Inhibitor; Dihydrotestosterone; DNA, Complementary; Humans; Immune Sera; Male; Metribolone; Nandrolone; Prostate; Prostate-Specific Antigen; Prostatic Neoplasms; RNA, Messenger; Testosterone; Tumor Cells, Cultured	1994
Androgen induction of a human prostate-specific kallikrein, hKLK2: characterization of an androgen response element in the 5' promoter region of the gene. Biochemistry, 1993, Jun-29, Volume: 32, Issue:25 Topics: Androgens; Base Sequence; Chloramphenicol O-Acetyltransferase; Dihydrotestosterone; DNA-Binding Proteins; Enzyme Induction; Gene Expression Regulation, Enzymologic; Humans; Kallikreins; Kinetics; Male; Molecular Sequence Data; Nandrolone; Oligodeoxyribonucleotides; Promoter Regions, Genetic; Prostate; Prostate-Specific Antigen; Prostatic Neoplasms; Receptors, Androgen; RNA, Messenger; Sequence Deletion; Transcription, Genetic; Transcriptional Activation; Transfection; Tumor Cells, Cultured	1993
Transcriptional and posttranscriptional regulation of human androgen receptor expression by androgen. Molecular endocrinology (Baltimore, Md.), 1993, Volume: 7, Issue:7 Topics: Androgens; Antibodies; Base Sequence; Blotting, Northern; Breast Neoplasms; Cells, Cultured; Down-Regulation; Fibroblasts; Gene Expression Regulation; Humans; Immunohistochemistry; Male; Molecular Sequence Data; Nandrolone; Prostatic Neoplasms; Protein Processing, Post-Translational; Receptors, Androgen; RNA, Messenger; Time Factors; Transcription, Genetic; Transfection; Tumor Cells, Cultured	1993
Preclinical evaluation of fluorine-18-labeled androgen receptor ligands in baboons. Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 1996, Volume: 37, Issue:6 Topics: Animals; Dihydrotestosterone; Drug Evaluation, Preclinical; Fluorine Radioisotopes; Male; Nandrolone; Papio; Prostate; Prostatic Neoplasms; Receptors, Androgen; Testosterone Congeners; Tomography, Emission-Computed	1996
Androgens stimulate fatty acid synthase in the human prostate cancer cell line LNCaP. Cancer research, 1997, Mar-15, Volume: 57, Issue:6 Topics: Adenocarcinoma; Androgen Antagonists; Androgens; Anilides; Dihydrotestosterone; Dose-Response Relationship, Drug; Enzyme Induction; Fatty Acid Synthases; Gene Expression Regulation, Neoplastic; Humans; Lipids; Male; Metribolone; Nandrolone; Neoplasm Proteins; Nitriles; Prostatic Neoplasms; Receptors, Androgen; Testosterone; Testosterone Congeners; Tosyl Compounds; Tumor Cells, Cultured	1997
Clathrin gene expression is androgen regulated in the prostate. Endocrinology, 1998, Volume: 139, Issue:4 Topics: Androgens; Animals; Blotting, Northern; Clathrin; Gene Expression Regulation; Humans; Kinetics; Male; Nandrolone; Polymerase Chain Reaction; Prostate; Prostatic Neoplasms; Rats; RNA, Messenger; Testosterone; Testosterone Congeners; Tumor Cells, Cultured	1998
Novel steroid-linked conjugates of 17 beta-[N-[N'-(2-chloroethyl)-N'-nitroso]carbamoyl]amino acids and their antineoplastic activity against Noble Nb prostate carcinoma model in rats. Anti-cancer drug design, 1998, Volume: 13, Issue:7 Topics: Amino Acids; Animals; Antineoplastic Agents; Male; Nandrolone; Prostatic Neoplasms; Rats; Rats, Sprague-Dawley; Receptors, Androgen; Structure-Activity Relationship	1998
Prostate-specific antigen (PSA) promoter-driven androgen-inducible expression of sodium iodide symporter in prostate cancer cell lines. Cancer research, 1999, May-01, Volume: 59, Issue:9 Topics: Adenocarcinoma; Androgens; Carrier Proteins; Cell Membrane; DNA, Complementary; Gene Expression Regulation, Neoplastic; Genetic Vectors; Humans; Iodides; Male; Membrane Proteins; Nandrolone; Neoplasms, Hormone-Dependent; Organ Specificity; Prostate-Specific Antigen; Prostatic Neoplasms; Recombinant Fusion Proteins; Symporters; Transfection; Tumor Cells, Cultured	1999
Different proportions of various prostate-specific antigen (PSA) and human kallikrein 2 (hK2) forms are present in noninduced and androgen-induced LNCaP cells. The Prostate, 2000, Aug-01, Volume: 44, Issue:3 Topics: alpha 1-Antichymotrypsin; Antibodies, Monoclonal; Chromatography, Affinity; Chromatography, High Pressure Liquid; Gene Expression Regulation, Neoplastic; Humans; Male; Nandrolone; Prostate; Prostate-Specific Antigen; Prostatic Neoplasms; Protein Isoforms; Sequence Analysis, Protein; Testosterone Congeners; Tissue Kallikreins; Tumor Cells, Cultured	2000
Peroxisome proliferator-activated receptor alpha is an androgen-responsive gene in human prostate and is highly expressed in prostatic adenocarcinoma. Clinical cancer research : an official journal of the American Association for Cancer Research, 2000, Volume: 6, Issue:8 Topics: Adenocarcinoma; Androgens; Blotting, Northern; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Humans; Immunohistochemistry; In Situ Hybridization; Male; Nandrolone; Prostate; Prostatic Neoplasms; Receptors, Cytoplasmic and Nuclear; Testosterone Congeners; Transcription Factors; Tumor Cells, Cultured	2000
Human cell lines as an in vitro/in vivo model for prostate carcinogenesis and progression. The Prostate, 2001, Volume: 47, Issue:1 Topics: Alkylating Agents; Animals; Carcinogenicity Tests; Cell Adhesion; Cell Culture Techniques; Cell Division; Chromosome Aberrations; Chromosome Disorders; Disease Progression; Dose-Response Relationship, Drug; Epidermal Growth Factor; Humans; Keratins; Male; Methylnitrosourea; Mice; Mice, Nude; Nandrolone; Neoplasm Invasiveness; Prostate-Specific Antigen; Prostatic Neoplasms; Receptors, Androgen; Transforming Growth Factor beta; Tumor Cells, Cultured	2001
Silymarin inhibits function of the androgen receptor by reducing nuclear localization of the receptor in the human prostate cancer cell line LNCaP. Carcinogenesis, 2001, Volume: 22, Issue:9 Topics: Androgen Receptor Antagonists; Cell Division; Cell Nucleus; Down-Regulation; Humans; Male; Nandrolone; Prostate-Specific Antigen; Prostatic Neoplasms; Receptors, Androgen; Silymarin; Tacrolimus Binding Proteins; Testosterone Congeners; Tissue Kallikreins; Transcriptional Activation; Transfection; Tumor Cells, Cultured	2001
Melatonin elicits nuclear exclusion of the human androgen receptor and attenuates its activity. The Prostate, 2001, Oct-01, Volume: 49, Issue:2 Topics: Androgen Receptor Antagonists; Blotting, Western; Cell Nucleus; Humans; Immunohistochemistry; Male; Melatonin; Nandrolone; Prostatic Neoplasms; Receptors, Androgen; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Transfection; Tumor Cells, Cultured	2001
Tumor-promoting phorbol ester down-regulates the androgen induction of prostate-specific antigen in a human prostatic adenocarcinoma cell line. Cancer research, 1992, Mar-15, Volume: 52, Issue:6 Topics: Alkaloids; Antigens, Neoplasm; Biomarkers, Tumor; Calcimycin; Colforsin; Dose-Response Relationship, Drug; Down-Regulation; Humans; Male; Nandrolone; Phorbols; Prostate-Specific Antigen; Prostatic Neoplasms; RNA, Messenger; Staurosporine; Testosterone Congeners; Tetradecanoylphorbol Acetate; Tumor Cells, Cultured	1992
Soluble and nuclear type I and II androgen-binding sites in benign hyperplasia and cancer of the human prostate. Urological research, 1992, Volume: 20, Issue:2 Topics: Aged; Binding Sites; Humans; Male; Nandrolone; Predictive Value of Tests; Prostate; Prostatic Hyperplasia; Prostatic Neoplasms; Radioligand Assay; Receptors, Androgen; Testosterone Congeners; Tritium	1992
Divergent responses to epidermal growth factor in hormone sensitive and insensitive human prostate cancer cell lines. British journal of cancer, 1992, Volume: 65, Issue:2 Topics: Blotting, Western; Cell Division; DNA, Neoplasm; Epidermal Growth Factor; ErbB Receptors; Humans; Male; Nandrolone; Prostatic Neoplasms; Thymidine; Tumor Cells, Cultured	1992
Androgen increases androgen receptor protein while decreasing receptor mRNA in LNCaP cells. Molecular and cellular endocrinology, 1991, Volume: 76, Issue:1-3 Topics: Androgens; Base Sequence; Blotting, Western; Cell Line; Dihydrotestosterone; DNA; Down-Regulation; Humans; Ligands; Male; Molecular Sequence Data; Nandrolone; Prostatic Neoplasms; Receptors, Androgen; RNA, Messenger; Testosterone Congeners; Tumor Cells, Cultured	1991
Effects of androgen on intracellular calcium of LNCaP cells. Biochemical and biophysical research communications, 1991, Aug-30, Volume: 179, Issue:1 Topics: Calcium; Cell Line; Dihydrotestosterone; Fura-2; Humans; Kinetics; Male; Nandrolone; Prostatic Neoplasms; Spectrometry, Fluorescence; Testosterone Congeners; Time Factors; Verapamil	1991
The synthetic androgen mibolerone induces transient suppression of the transformed phenotype in an androgen responsive human prostatic carcinoma cell line. Andrologia, 1990, Volume: 22 Suppl 1 Topics: Androgen Antagonists; Androgens; Cell Division; Cell Transformation, Neoplastic; Cyproterone; Cyproterone Acetate; Dihydrotestosterone; Flutamide; Humans; Male; Nandrolone; Prostatic Neoplasms; Receptors, Androgen; RNA, Messenger; Tumor Cells, Cultured	1990
The proliferative effect of "anti-androgens" on the androgen-sensitive human prostate tumor cell line LNCaP. Endocrinology, 1990, Volume: 126, Issue:3 Topics: Androgens; Antibodies; Cell Division; Dihydrotestosterone; Estradiol; Flutamide; Humans; Male; Nandrolone; Prostatic Neoplasms; Receptors, Androgen; Testosterone Congeners; Tumor Cells, Cultured	1990
Distribution of pituitary cell types in relation to the histology of the prostate in elderly men. An analysis in an autopsy series. Acta pathologica et microbiologica Scandinavica. Section A, Pathology, 1973, Volume: 81, Issue:4 Topics: Adrenal Cortex Hormones; Adult; Age Factors; Aged; Atrophy; Autopsy; Body Height; Body Weight; Diabetes Mellitus; Estrogens; Humans; Liver Cirrhosis; Male; Middle Aged; Nandrolone; Periodic Acid; Pituitary Gland; Prostate; Prostatectomy; Prostatic Diseases; Prostatic Hyperplasia; Prostatic Neoplasms; Regression Analysis; Staining and Labeling	1973
Hormones in advanced cancer. British medical journal, 1971, Jun-26, Volume: 2, Issue:5764 Topics: Acne Vulgaris; Adrenal Cortex Hormones; Adrenalectomy; Androgens; Androstanols; Breast Neoplasms; Estrogens; Female; Hirsutism; Hormones; Humans; Hypercalcemia; Hypertension; Hypophysectomy; Male; Nandrolone; Norethindrone; Ovarian Neoplasms; Progesterone; Prostatic Neoplasms; Thyroid Hormones; Thyroid Neoplasms; Urogenital Neoplasms; Uterine Neoplasms; Vasopressins	1971
[Study of prostatic carcinogenesis, using 20-methyl-cholanthrene in albino rats]. Chirurgia e patologia sperimentale, 1968, Volume: 16, Issue:5 Topics: Adenocarcinoma; Adrenocorticotropic Hormone; Animals; Carcinoma, Squamous Cell; Hormones; Male; Methylcholanthrene; Nandrolone; Neoplasms, Experimental; Progesterone; Prostatic Neoplasms; Rats; Sarcoma; Triiodothyronine	1968
[Long-term treatment of medullary insufficiency with androgens]. Minerva medica, 1971, Jun-27, Volume: 62, Issue:51 Topics: Adenoma; Adult; Androgens; Blood Transfusion; Bone Marrow Diseases; Female; Follow-Up Studies; Growth; Hemodynamics; Humans; Infant; Male; Nandrolone; Prostatic Neoplasms; Stanozolol; Testosterone; Time Factors; Virilism	1971